169 SatyamA.HockerM
Sudden appetite changes can also indicate thyroid dysfunction, uncontrolled diabetes, or other endocrine disorders that require investigation
this may constitute a protocol deviation requiring formal documentation and reporting Do not source retatrutide outside of an approved clinical trial it is not currently licensed for use in the UK, and obtaining it through unofficial channels carries significant safety and legal risks Consult the MHRA website (www.gov.uk/mhra) for the latest information on the regulatory status of retatrutide in the UK Once retatrutide receives regulatory approval, an official SmPC will be published, providing definitive storage guidance for both healthcare professionals and patients
Because blood thinners require very precise levels in the blood to be both safe and effective, this timing shift is the main reason doctors want to monitor patients closely
Liraglutide 3.0 mg was the first agent approved for adolescent obesity, and the STEP-TEENS trial demonstrated that once-weekly semaglutide reduced body mass index (BMI) by a mean 16.1 percentage points versus 0.6 with placebo in adolescents aged 1218 years [128]
Studies show that patients on GLP-1 therapy experience reductions in both total cholesterol and triglycerides, even independent of weight loss
